BeaconOne Healthcare Partners

BeaconOne Healthcare Partners is a global life sciences strategy consulting firm founded in 2021 by two consulting executives with decades of combined experience. The firm specializes in supporting medical technology innovators and investors across medical devices, diagnostics, and biopharmaceuticals through strategic guidance on complex business decisions related to market access and commercialization.

The firm employs an integrated approach that combines market landscape analysis, value proposition development, evidence planning, reimbursement strategy, and health economics. BeaconOne's services span from market opportunity assessment and competitor analysis to payer research, evidence gap identification, and health economic modeling. The team works with in-country experts globally to ensure understanding of local market dynamics and maintains direct access to payers, financial risk holders, and key opinion leaders.

Both co-founders served as executives at Boston Healthcare Associates before its 2021 acquisition, bringing their experience supporting hundreds of assignments across the life sciences sector. The firm was nominated for Best MedTech Market Access Consultancy by MedTech World in 2025 and maintains an active research practice, publishing systematic literature reviews and collaborating on clinical presentations.

Consider BeaconOne Healthcare Partners when you need strategic guidance at the intersection of evidence generation, payer requirements, and market access planning. The firm excels in situations where understanding financial risk holder perspectives is critical to commercial success, such as developing evidence strategies that address both regulatory approval and payer coverage needs simultaneously.

Expect a consulting engagement that integrates multiple workstreams rather than treating market landscape, value proposition, evidence planning, and health economics as separate deliverables. The firm's approach to validating strategies through direct payer research helps reduce uncertainty around coverage and reimbursement decisions.

BeaconOne Healthcare Partners exclusively serves the life sciences sector, with particular depth in medical technology market access. The firm addresses healthcare-specific challenges including CMS reimbursement processes (NTAP, pass-through, ICD-10, HCPCS coding), PAMA clinical laboratory payment reforms, payer coverage policies, and health technology assessment requirements. Managing Partner Tom Goss currently serves as a CMS MEDCAC appointee, providing direct insight into Medicare coverage decision-making.

The firm has developed specialized expertise in emerging healthcare areas including digital health reimbursement models, molecular diagnostics, and AI-enabled medical technologies where traditional buy-and-bill purchasing models may not apply.

The ideal client is a medical device, diagnostic, or biopharmaceutical company at an inflection point requiring strategic market access guidance. This includes startups preparing evidence strategies before pivotal trials, growth-stage companies planning global market sequencing, or established firms launching novel technologies that challenge traditional reimbursement pathways. Investors conducting due diligence on healthcare assets also benefit from BeaconOne's integrated commercial assessment approach.